Details of the IPOPI position statement regarding access to immunoglobulin therapies for patients living with a primary immunodeficiency can be found here:
ImmUnity Canada is a national charity with five provincial chapters across the country.
We empower Canadians impacted by immunodeficiency disorders to live well through education, support, advocacy, community-building, and research.
Read the latest news and updates from ImmUnity Canada.
In this session, Dr Nicola Wright will give an overview of her groundbreaking gene therapy trial for CD3 SCID and the potential implications for this...
Discover the latest breakthroughs in diagnosing and treating primary immunodeficiency. This session will highlight cutting-edge technologies, innovative...
Patients and families bring vital lived experience to research—shaping priorities, improving study design, and ensuring outcomes that truly matter. This...